A detailed history of New York State Common Retirement Fund transactions in Annexon, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 14,168 shares of ANNX stock, worth $71,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,168
Previous 34,668 59.13%
Holding current value
$71,690
Previous $170,000 50.59%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$4.49 - $7.2 $92,045 - $147,600
-20,500 Reduced 59.13%
14,168 $84,000
Q2 2024

Jul 31, 2024

BUY
$4.33 - $6.79 $98,381 - $154,275
22,721 Added 190.18%
34,668 $170,000
Q1 2024

May 07, 2024

BUY
$4.03 - $7.81 $44,527 - $86,292
11,049 Added 1230.4%
11,947 $86,000
Q4 2023

Feb 01, 2024

SELL
$1.63 - $4.63 $143 - $407
-88 Reduced 8.92%
898 $4,000
Q3 2023

Nov 07, 2023

SELL
$2.13 - $3.84 $56,900 - $102,581
-26,714 Reduced 96.44%
986 $2,000
Q2 2023

Aug 07, 2023

BUY
$2.1 - $6.37 $58,170 - $176,449
27,700 New
27,700 $98,000
Q2 2022

Aug 04, 2022

SELL
$2.11 - $4.06 $45,987 - $88,487
-21,795 Reduced 98.98%
224 $1,000
Q1 2022

May 05, 2022

BUY
$2.73 - $11.94 $101 - $441
37 Added 0.17%
22,019 $60,000
Q4 2021

Feb 02, 2022

SELL
$11.49 - $22.0 $30,379 - $58,168
-2,644 Reduced 10.74%
21,982 $253,000
Q3 2021

Nov 02, 2021

SELL
$16.35 - $23.4 $70,648 - $101,111
-4,321 Reduced 14.93%
24,626 $458,000
Q2 2021

Aug 02, 2021

BUY
$17.81 - $27.48 $198,243 - $305,879
11,131 Added 62.48%
28,947 $652,000
Q1 2021

May 11, 2021

BUY
$22.0 - $35.01 $97,152 - $154,604
4,416 Added 32.96%
17,816 $496,000
Q4 2020

Feb 08, 2021

BUY
$20.81 - $30.55 $139,427 - $204,685
6,700 Added 100.0%
13,400 $335,000
Q3 2020

Nov 05, 2020

BUY
$17.5 - $30.23 $117,250 - $202,541
6,700 New
6,700 $203,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $241M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.